8 Coupons
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
the report "correctly points out that there really was no playbook for dealing with what was an unprecedented health crisis," san diego mayor kevin faulconer said. . .
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .
stephen silberstein, md, director, jefferson university headache center. .